| Literature DB >> 19325772 |
Abstract
Various etiological factors contributing to the development of mycotoxic nephropathy in farm animals and humans are reviewed. The possible synergistic effect between ochratoxin A (OTA) and other mycotoxins, as penicillic acid (PA) and fumonisin B(1) (FB(1)), contributing to this nephropathy is also considered and discussed. The most convenient ways of prophylaxis and various preventive measures against OTA contamination of feeds or foods are reviewed. A reference is made concerning the most successful methods of veterinary hygiene control in the slaughterhouses in order to prevent the entering of OTA in commercial channels with a view to human health. The economic efficacy of these prophylactic procedures is also considered. An evaluation of human exposure to OTA is made.Entities:
Keywords: BEN - Balkan endemic nephropathy; Balkan endemic nephropathy; FB1 - fumonisin B1; MAN - mycotoxic avian nephropathy; MN - mycotoxic nephropathy; MNFA - mycotoxic nephropathy in farm animals; MPN - mycotoxic porcine nephropathy; OTA - ochratoxin A; OTα - ochratoxin α; PA - penicillic acid; fumonisin B1; hygiene control; mycotoxic nephropathy; ochratoxin A; pathogenesis; penicillic acid; preventive measures; synergism
Year: 2008 PMID: 19325772 PMCID: PMC2635690 DOI: 10.3390/ijms9040578
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1.Range of enlargement and mottled or pale appearance of kidneys from pigs with MPN at age of 6–8 months taken at slaughtered time, including an example (left) with enlarged renal lymph nodes.
Figure 2.Kidney with neoplastic tissue (fibroadenoma) - spontaneous case of MPN in Bulgaria.
Figure 3.Role of OTA in the renal diseases MPN and BEN.
Mean values of body weight (b.w.) after consecutive two-week periods in groups of chicks treated with OTA and various antidotes [94].
| OTA (ppm) | antidotes | 1 day b.w. (g) | 14 day b.w. (g) | 28 day b.w. (g) | 42 day b.w. (g) |
|---|---|---|---|---|---|
| 1 ppm | - | 80.0 ±1.9 | 253.0 | 428.53c ±15.2 | 727.02c ±22.1 |
| 5 ppm | - | 81.0 ±1.5 | 174.8 | 283.1 | 423.5 |
| 5 ppm | L-β phenylalanine | 81.5 ±6.7 | 233.51c ±7.6 | 374.03c ±11.2 | 623.53c ±14.8 |
| 5 ppm | Roxazyme G | 80.5 ±2.0 | 237.01c ±6.2 | 380.53c ±14.7 | 691.03c ±10.9 |
| 5 ppm | Sesame seed | 81.5 ±2.4 | 224.52c ±8.3 | 368.53c ±21.8 | 704.03c ±16.5 |
| 5 ppm | Artichoke-extract | 79.5 ±3.3 | 219.53c ±6.3 | 364.53c ±15.0 | 646.53c ±22.0 |
| Control
| -
| 82.0 ±2.5
| 255.0 | 509.0 | 836.0 |
| Chicks number | - | 20 | 20 | 20 | 20 |
- SEM (standard error of the mean)
– Significant difference (p < 0.05)
– Very significant difference (p < 0.01)
– Extremely significant difference compared to the control group (p < 0.001)
- Extremely significant difference compared to the 5 ppm group without antidote (p < 0.001)
Mean values of haemagglutinin inhibiting antibody titers (HIAT) in groups of chicks treated with OTA and various antidotes - on day 21 after vaccination against Newcastle disease (28 days from the beginning of the experiment) [94].
| OTA (ppm) | Antidotes | HIAT (HU/ml) | Number of chicks |
|---|---|---|---|
| 1 ppm | - | 340.0 | 20 |
| 5 ppm | - | 7.1 | 20 |
| 5 ppm | L-β phenylalanine | 31.43c ±4.0 | 20 |
| 5 ppm | Roxazyme G | 16.4 | 20 |
| 5 ppm | Sesame seed | 280.0 | 20 |
| 5 ppm
| Artichoke-extract
| 150.03 | 20
|
| Control | - | 353.3 | 20 |
- SEM (standard error of the mean)
– Extremely significant difference compared to the control group (p < 0.001)
- Extremely significant difference compared to the 5 ppm group without antidote (p < 0.001)
Mean serum values of total protein, urea and creatinine in groups of chicks treated with OTA and various antidotes (70th days) [94].
| OTA (ppm) | Antidotes | Total protein (g/l) | Urea (mmol/l) | Creatinine (μmol/l) | Number of chicks |
|---|---|---|---|---|---|
| 1 ppm | - | 31.271c ±1.60 | 2.463b ±0.061 | 124.0 | 10 |
| 5 ppm | - | 23.26 | 2.86 | 514.4 | 10 |
| 5 ppm | L-β phenylalanine | 25.963a ±1.00 | 1.88 | 309.53b ±16.8 | 10 |
| 5 ppm | Roxazyme G | 27.663c ±0.55 | 2.483c ±0.032 | 240.63c ±16.7 | 10 |
| 5 ppm | Sesame seed | 26.873c ±0.54 | 2.513b ±0.047 | 191.93c ±15.2 | 10 |
| 5 ppm
| Artichoke-extract
| 26.493b ±0.62
| 2.523b ±0.022
| 275.13b ±20.4
| 10
|
| Control | - | 36.54 | 1.81 | 119.8 | 10 |
- SEM (standard error of the mean)
– Significant difference compared to the control group (p < 0.05)
– Very significant difference compared to the control group (p < 0.01)
– Extremely significant difference compared to the control group (p < 0.001)
– Significant difference compared to the 5 ppm group without antidote (p < 0.05)
– Very significant difference compared to the 5 ppm group without antidote (p < 0.01)
- Extremely significant difference compared to the 5 ppm group without antidote (p < 0.001)
Mean serum values of cholesterol and uric acid in groups of chicks treated with OTA (130, 305 and 790 ppb) and PA (1000–2000 ppb), and various antidotes (70th day) [26].
| OTA (ppb) | Antidotes | Cholesterol (mmol/l) | Uric acid (μmol/l) | Number of chicks |
|---|---|---|---|---|
| 130 ppb | - | 3.901b ±0.20 | 211.7 | 5 |
| 305 ppb | - | 3.752a ±0.17 | 458.0 | 5 |
| 790 ppb | - | 3.11 | 534.1 | 5 |
| 790 ppb | Artichoke-extract | 3.801a ±0.22 | 222.4 | 5 |
| 790 ppb
| ROSALLSAT® | 4.63 | 182.2 | 5
|
| Control | - | 5.09 | 162.6 | 10 |
- SEM (standard error of the mean)
– Significant difference compared to the control group (p < 0.05)
– Very significant difference compared to the control group (p < 0.01)
– Extremely significant difference compared to the control group (p < 0.001)
– Significant difference compared to the 790 ppb group without antidote (p < 0.05)
– Very significant difference compared to the 790 ppb group without antidote (p < 0.01)
- Extremely significant difference compared to the 790 ppb group without antidote (p < 0.001)
Calculation of the daily intake of OTA in patients suffering from BEN in endemic of BEN areas and in healthy patients from nonendemic areas in Bulgaria [1, 124].
| Areas | Year | Positive samples (%) | Cp (ng/ml) per day) | Reference | K0 (ng/kg b. w. |
|---|---|---|---|---|---|
| endemic of BEN | 1986 | 23.3 | 20.0 | [ | 26.8 |
| 1989 | 29.2 | 27.2 | 36.4 | ||
| 1990 | 25.0 | 25.0 | 34.2 | ||
| nonendemic | 1986 | 7.7 | 10.0 | [ | 13.4 |
| 1989 | 6.6 | 0 > 2 | 0 > 2.7 | ||
| 1990 | 6.6 | 8.0 | 10.7 |
Cp - average concentration of OTA in plasma
K0 - average daily intake
| liver | −0,7 ± 0,7 X |
| muscles | − 0,6 ± 0,4 X |
| fat tissue | −0,8 ± 0,3 X, |
| where “X” is the concentration of OTA in kidneys in μg/kg and X≥2 | |